Literature DB >> 3107472

Expression of a functional 78,000 dalton mammalian flavoprotein, NADPH-cytochrome P-450 oxidoreductase, in Escherichia coli.

T D Porter, T E Wilson, C B Kasper.   

Abstract

A cDNA containing the complete coding nucleotide sequence for rat liver NADPH-cytochrome P-450 oxidoreductase was constructed from two overlapping cDNA clones. This full-length cDNA was inserted into the plasmid expression vector pCQV2, transfected into Escherichia coli, and expressed reductase was identified in cell lysates by electrophoresis followed by electrophoretic transfer to nitrocellulose and immunodetection. Various strains were screened for maximal expression and minimal intracellular degradation of the expressed protein, and strain C-1A was selected for preparation of the expressed enzyme. Induced cells from 12-liter cultures were pelleted, lysed in a French press, and the 50,000g supernate was fractionated by DEAE-cellulose and 2'5'-ADP agarose chromatography. Thirty-five grams of packed cells yielded approximately 2 mg of affinity-purified protein that was essentially free of E. coli proteins. The final preparation exhibited considerable proteolytic degradation and only an estimated 5-10% of the immunoreactive protein was undegraded. Four principal forms could be distinguished upon sodium dodecyl sulfate-polyacrylamide gel electrophoresis, with molecular weights of 65,000, 66,000, 74,000, and 78,000, the latter being equivalent to that of intact reductase. High-performance liquid chromatography with a Spherogel-DEAE column resolved these forms but resulted in the loss of the 78-kDa form; three peaks eluted with molecular weights of 65,000. Several of the HPLC fractions exhibited cytochrome c reductase activity, indicating correct incorporation of both flavin prosthetic groups, with the 66-kDa form showing the highest specific activity (44 mumol of cytochrome c reduced/mg reductase/min at 22 degrees C). HPLC assay of flavin content demonstrated equimolar FMN and FAD concentrations, and spectrophotometric analysis of the 66-kDa form revealed a spectrum essentially identical to that of reductase purified from rat liver. When the affinity-purified preparation was reconstituted with cytochrome P-450c, rates of benzo[a]pyrene metabolism approaching rates observed with liver reductase were obtained, indicating that the undegraded component in the affinity-purified preparation was able to interact with cytochrome P-450 and catalyze electron transfer from NADPH.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3107472     DOI: 10.1016/0003-9861(87)90111-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  12 in total

1.  Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5.

Authors:  Rüdiger Kaspera; Suresh B Naraharisetti; Eric A Evangelista; Kristin D Marciante; Bruce M Psaty; Rheem A Totah
Journal:  Biochem Pharmacol       Date:  2011-06-24       Impact factor: 5.858

2.  Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis.

Authors:  Rüdiger Kaspera; Suresh B Naraharisetti; Bani Tamraz; Tariku Sahele; Matthew J Cheesman; Pui-Yan Kwok; Kristin Marciante; Susan R Heckbert; Bruce M Psaty; Rheem A Totah
Journal:  Pharmacogenet Genomics       Date:  2010-10       Impact factor: 2.089

3.  Differentially regulated NADPH:cytochrome P450 oxidoreductases in parsley.

Authors:  E Koopmann; K Hahlbrock
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

4.  Modulation of the cytochrome P450 reductase redox potential by the phospholipid bilayer.

Authors:  Aditi Das; Stephen G Sligar
Journal:  Biochemistry       Date:  2009-12-29       Impact factor: 3.162

5.  Purification, characterization, and cDNA cloning of an NADPH-cytochrome P450 reductase from mung bean.

Authors:  M S Shet; K Sathasivan; M A Arlotto; M C Mehdy; R W Estabrook
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

6.  Crystallization and preliminary x-ray studies of NADPH-cytochrome P450 reductase.

Authors:  S Djordjevic; D L Roberts; M Wang; T Shea; M G Camitta; B S Masters; J J Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

7.  Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli.

Authors:  H J Barnes; M P Arlotto; M R Waterman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

8.  Purification and reconstitution of the electron transport components for 6-deoxyerythronolide B hydroxylase, a cytochrome P-450 enzyme of macrolide antibiotic (erythromycin) biosynthesis.

Authors:  A Shafiee; C R Hutchinson
Journal:  J Bacteriol       Date:  1988-04       Impact factor: 3.490

9.  RNA interference of NADPH-cytochrome P450 reductase results in reduced insecticide resistance in the bed bug, Cimex lectularius.

Authors:  Fang Zhu; Sarah Sams; Tim Moural; Kenneth F Haynes; Michael F Potter; Subba R Palli
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

Review 10.  Cytochrome P450 proteins and potential utilization in biodegradation.

Authors:  F P Guengerich
Journal:  Environ Health Perspect       Date:  1995-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.